The largest database of trusted experimental protocols

Seqcap ez hypercap workflow

Manufactured by Roche
Sourced in United States

The SeqCap EZ HyperCap Workflow is a laboratory equipment product designed for targeted DNA sequencing. It provides a streamlined and efficient method for capturing and enriching specific genomic regions of interest prior to sequencing. The product allows for the selective capture and amplification of target sequences, enabling focused and cost-effective sequencing analysis.

Automatically generated - may contain errors

8 protocols using seqcap ez hypercap workflow

1

Targeted NGS Profiling of Myeloid Malignancies

Check if the same lab product or an alternative is used in the 5 most similar protocols
BCR-ABL1 KD amplicon libraries were prepared using the Nextera XT DNA Library Prep Kit (cat. number FC-131-1096, Illumina, San Diego, CA, USA).
The DNA custom-designed NGS panel of 33 genes often mutated in myeloid malignancies (Supplementary Table S2) was analyzed using SeqCap EZ HyperCap Workflow (Roche, San Diego, CA, USA).
Sequence analysis and mutation identification were performed using NextGENe software (SoftGenetics, State College, PA, USA).
+ Open protocol
+ Expand
2

Hereditary Cancer Gene Panel Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA extracted from peripheral blood was analyzed using a capture-based approach with custom-designed probes (KAPA HyperExplore Max 3 Mb T1, NimbleGen, Roche) targeting all coding exons and 20 bp of flanking intronic regions of 52 genes involved in hereditary predisposition to cancer. Sample preparation was performed according to the SeqCap EZ HyperCap Workflow (Roche NimbleGen, Pleasanton, CA) as previously described.19 (link) Sequencing was performed on the DNBSEQ-G400 NGS platform (MGI Tech, Beishan Industrial Zone, Shenzhen, PR China).
+ Open protocol
+ Expand
3

Cancer Gene Variant Identification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracted genomic DNA samples were placed into three groups based on genomic profile size ranges of <700 bp, 700–1100 bp, and 1100–2500 bp, and were subject to fragmentation to 180–220 bp using a Covaris E220 Series Focused-ultrasonicator (Covaris, Inc., Woburn, MA) with recommended settings and treatment times of 20, 50, and 60 s, respectively. Libraries were then prepared with the SeqCap EZ HyperCap workflow according to manufacturer’s protocol (Roche NimbleGen, Inc., Madison, WI, USA) and captured as a 24-plex pool with a custom target design that enriched for all coding exons, as well as 20 bp of the 5′ and 3′ flanking intronic regions for 37 hereditary cancer genes. Four captured libraries (96 samples) were diluted to 4 nM each and pooled for sequencing on the NextSeq according to the manufacturer’s protocol (Illumina, San Diego, CA, USA). The libraries were sequenced using the NextSeq version 2 mid output reagent kit to generate 2 × 150 bp paired-end reads. Post-sequencing file conversion generated FASTQ files for sequence alignment with the NextGene software version 2.4.1 (SoftGenetics, LLC, State College, PA, USA) using the recommended settings. The identified variants were filtered by an allelic fraction >10% and were assessed based on CAP guidelines for pathogenicity.
+ Open protocol
+ Expand
4

Targeted Sequencing of MYC and IGH Loci

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NGS libraries used in this study were created, pooled, and enriched according to the SeqCap EZ HyperCap Workflow (Roche, Basel, Switzerland), using the NimbleDesign software to design the set of SeqCap EZ Choice hybridization probes (Roche) covering the following two regions in the human GRCh38 genome assembly: chr8:127,351,112–128,172,319 (MYC) and chr14:105,199,125–106,860,200 (IGH). The estimated coverage of the design equaled 92.8%. The obtained enriched multilibrary was then sequenced on a MiSeq next-generation sequencer (Illumina, San Diego, CA, USA) in paired-end mode (2 × 76 bp).
+ Open protocol
+ Expand
5

Promoter Panel Hybrid Capture Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
1 μg each of the three replicate pools was hybridized with a custom panel of probes designed using NimbleDesign software (Roche) to cover our promoter panel of interest (Supplementary Table 1). Samples were processed as per the SeqCap EZ HyperCap Workflow (Roche). Briefly, libraries were hybridized with the probe pool first by denaturing at 95 °C for 5 min then incubating at 16 hr at 47 °C. Samples were captured using streptavidin capture beads and a post-capture PCR performed for 8 cycles. Samples were pooled and sequenced using a NextSeq 500 High Output kit (Illumina).
+ Open protocol
+ Expand
6

Viral RNA Extraction and Virome Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The extracted viral RNA was fragmented, and then reverse-transcribed into cDNA using the Maxima H Minus Double-Stranded cDNA synthesis kit, following the manufacturer’s protocol (Thermo Fisher Scientific, Massachusetts, USA). The synthesized cDNA was purified using the Nucleospin Gel and PCR Clean-up Kit (Macherey–Nagel, Düren, Germany) through column purification. Library preparation was conducted using the SeqCap EZ HyperCap Workflow with the KAPA Hyper Prep Kit and Single-Indexed SeqCap Adapter Kit A (Roche Diagnostics, Mannheim, Germany). For virome analyses, the paired-end FASTQ files generated from sequencing were analyzed using the cloud-based online classification tool Genome Detective, utilizing default parameters.
+ Open protocol
+ Expand
7

Targeted NGS of Microdissected Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor areas were microscopically selected on HE‐stained slides, and the marked region was isolated from serial 5‐µm‐thick unstained sections by microdissection to obtain a tumor cell content (>70%) as assessed microscopically prior to DNA extraction (except for the lymph node metastasis of patient OC122 with an uncertain fraction of tumor cells). The SeqCap EZ HyperCap Workflow (Roche) was used for targeted next‐generation sequencing (NGS). The Kapa High Throughput Library Preparation Kit (Roche) with 1 µg of sonicated gDNA with an average length between 180 and 220 bp (Covaris M220) was used for end repair and A‐tailing, adapter ligation, and library amplification. The HyperCap Target Enrichment Kit (Roche) was used for hybridizing the libraries, washing, and amplification of captured libraries. MiSeq Reagent v3 600‐cycle kit and a MiSeq were used for paired‐end sequencing (2 × 150 cycles).
+ Open protocol
+ Expand
8

Targeted Sequencing of M. ulcerans from Swab Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
One sample sequenced in this study corresponded to the DNA extracted from a swab. No isolate was obtained. To sequence this DNA sample, we applied a method of DNA capture before performing a whole genone sequencing. A custom targeted sequence capture array for M. ulcerans was generated using the Roche NimbleGen SeqCap method (Madison, USA), biotinylated DNA probes were designed in silico to cover 100% of the genome M. ulcerans reference (GenBank: GCA_000013925.2, 1 chromosome and 1 plasmid). The probes that hybridized to human genome HG38 were removed. Libraries were prepared according to the SeqCap EZ Hyper Cap Workflow by Roche. In resume, 100ng gDNA were fragmented using a Covaris E200 targeting 180-220bp fragment size. We then proceed to prepare libraries using the Kapa Hyper Prep kit as recommended by Roche. We did hybridization of the samples for 64h. After incubation, samples were captured as recommended by the SeqCap EZ Hyper Cap Workflow user guide. The captured DNA was sequenced using a Nextseq 500 Mid Output format, paired-end 150bp.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!